Allspring Global Investments
ALXO icon

Allspring Global Investments’s ALX Oncology ALXO Stock Holding History

Allspring Global Investments’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$3 – 1775
2024
Q3 		$3 Buy
+2
New +$7 ﹤0.01% 2441
2023
Q2 		– Sell
-14,724
Closed -$66.6K – 2692
2023
Q1 		$66.6K Buy
14,724
+1,737
+13% +$13.2K ﹤0.01% 2194
2022
Q4 		$146K Sell
12,987
-59
-0.5% -$663 ﹤0.01% 1932
2022
Q3 		$124K Sell
13,046
-13,518
-51% -$158K ﹤0.01% 1990
2022
Q2 		$214K Buy
+26,564
New +$289K ﹤0.01% 1797

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Allspring Global Investments's ALXO Position: Q4 2024 in Review

Allspring Global Investments sold out of ALX Oncology (ALXO) in Q4 2024, closing a stake of 2 shares — an estimated $3 sold.

Allspring Global Investments first reported a position in ALXO in Q2 2022 and held it in 5 quarters. The position peaked at $214K in Q2 2022. 87 funds tracked by Wall St. Rank hold ALXO as of Q4 2024.

  • Allspring Global Investments reported no remaining ALX Oncology position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 2 ALX Oncology shares in Q4 2024, an estimated $3.
  • Allspring Global Investments first reported a position in ALX Oncology in Q2 2022 and held it in 5 quarters.
  • Allspring Global Investments's ALX Oncology position peaked at $214K in Q2 2022.
  • 87 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.